Lintuzumab

From WikiMD.org
Jump to navigation Jump to search
Lintuzumab
TermLintuzumab
Short definitionLintuzumab (lin-TOO-zoo-mab) A substance being studied for the treatment of myelodysplastic syndromes and some types of leukemia. It attaches to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Lintuzumab - (pronounced) (lin-TOO-zoo-mab) A substance being studied for the treatment of myelodysplastic syndromes and some types of leukemia. It attaches to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. It causes the immune system to kill these cells. Lintuzumab is a type of monoclonal antibody. Also called MoAb HuM195 and monoclonal antibody HuM195

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski